In this study, we demonstrated the feasibility of applying the U-maspin gene as a cell-free fetal DNA marker and the M-maspin gene as a cell-free total DNA marker in maternal plasma for the non-invasive prenatal detection of fetal trisomy 18 during the first trimester of pregnancy. The gene discussed is SERPINB5; the disease is trisomy 18.